SCHEMBL7202669

SCHEMBL7202669

CC(C)(CCSCCc1ccc(CSCCC(C)(C)C(=O)OCc2ccccc2)cc1)C(=O)OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 1/20 0.43
PTGER4 P35408 1/20 0.43
PTGER3 P43115 1/20 0.43
PTGER2 P43116 1/20 0.43
CYP2C19 P33261 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
ALPL P05186 1/20 0.42
ALPI P09923 1/20 0.42
ALPG P10696 1/20 0.42
HTT P42858 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALDH1A1 P00352 3/20 0.41
PPARA Q07869 4/20 0.41
PPARG P37231 2/20 0.41
IDO1 P14902 1/20 0.40
HPGD P15428 2/20 0.39
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6346285 0.95 CYP2C19 (0.46) CYP2C19SMN1; SMN2ALDH1A1PPARAPPARG
SCHEMBL6344402 0.88 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1HPGDNPC1RAB9A
SCHEMBL6345166 0.85 ALDH1A1 (0.46) SMN1; SMN2CYP3A4ALDH1A1RAB9ALMNA
SCHEMBL7202673 0.84 PPARA (0.39) CYP2C19ALDH1A1PPARAPPARGLMNA
SCHEMBL6346577 0.78 ELANE (0.44) CYP2C19SMN1; SMN2HTTCYP1A2ALDH1A1
SCHEMBL6342853 0.78 ALDH1A1 (0.46) SMN1; SMN2CYP3A4ALDH1A1RAB9ALMNA
SCHEMBL6352946 0.77 ALDH1A1 (0.40) CYP2C19SMN1; SMN2CYP1A2CYP3A4CYP2D6
SCHEMBL2152137 0.75 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1HPGDNPC1RAB9A
SCHEMBL6689309 0.75 ALDH1A1 (0.41) CYP2C19SMN1; SMN2ALDH1A1PPARAPPARG
SCHEMBL6393090 0.75 ALDH1A1 (0.53) SMN1; SMN2CYP3A4ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002030882-A9 SULFOXIDE AND BIS-SULFOXIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS INC (US) 2003-02-20 WO disclosed